XORTX Therapeutics OverviewXORTX Therapeutics Other Income Expense Net
Other Income/Expense Net for XRTX.
Quarterly Other Income/Expense
$14619.00
↓ 94.48% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$389375.00
↓ 81.48% YoY
Trailing 12 months ending Mar 31, 2026